New coronavirus new therapeutic agents in China currently include Ambavizumab/Romivizumab Injection and Nematrexate Tablet/Ritonavir Tablet combination. The above drugs are oral small molecule new coronavirus therapeutic drugs for the treatment of patients suffering from chronic kidney disease, cardiovascular disease, diabetes mellitus and other mild and moderate new coronavirus pneumonia. Adverse reactions that may result from taking the drug include hypertension, diarrhea, taste disorders, and myalgia. Patients need to take this drug under the guidance of a doctor, if you need to be used in conjunction with other drugs, it is recommended to carefully read the instructions and inform the attending physician, not to be used arbitrarily, severe hepatic and renal insufficiency should be cautious of using this drug. New coronavirus therapeutic drugs can not replace the vaccine, if you are eligible for the new coronavirus vaccine, please actively cooperate with the vaccination. In daily life, you need to take protective measures, avoid going to places with high traffic volume and confined areas, and wear a good mask when you go out. Tips] In this article, “new coronavirus pneumonia, new coronavirus pneumonia” has been renamed to “new coronavirus infection” on December 26, 2022, as announced by the National Health Commission.